-transparent.png){kind=logo}
In a randomized trial, pleurodesis was attempted with Corynebacterium parvum in one group and bleomycin in another. Patients with malignant pleural effusion which required repeated drainage were treated with instillation of one of these agents after complete drainage of the pleural effusion. There were 32 patients who could be evaluated. Sixty-five per cent of the patients treated with C. parvum had no recurrence after one treatment and another 29% after two treatments. In the bleomycin group, two patients needed only one treatment while the remainder - 13 out of 15 patients - needed further drainage treatments even after two instillations of the drug. The difference was highly significant (p less than 0.001).
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
July 1994,
Zhonghua hu li za zhi = Chinese journal of nursing,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
July 1985,
Thorax,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
January 1995,
Acta oncologica (Stockholm, Sweden),
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
February 1978,
British medical journal,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
October 1989,
Minerva medica,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
June 1980,
La Nouvelle presse medicale,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
January 1995,
Thorax,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
January 1983,
Thorax,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
December 1983,
Postgraduate medical journal,
G Hillerdal, and
J Kiviloog, and
E Nöu, and
L Steinholtz
February 2012,
Cancer investigation,
